NCT02719977View on ClinicalTrials.gov

A Phase I Study of CX5461

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 13, 2016

Primary Completion Date

January 30, 2020

Study Completion Date

January 18, 2023

Conditions
Cancer
Interventions
DRUG

CX5461

Trial Locations (3)

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

M5G 2M9

University Health Network, Toronto

All Listed Sponsors
collaborator

Senhwa Biosciences, Inc.

INDUSTRY

collaborator

Stand Up To Cancer

OTHER

lead

Canadian Cancer Trials Group

NETWORK

NCT02719977 - A Phase I Study of CX5461 | Biotech Hunter | Biotech Hunter